Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

79 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Monkeypox virus isolation from longitudinal samples in 11 hospitalised patients.
Callaby H, Olver J, Emery K, Richards KS, Killip M, Groves N, Beadsworth MBJ, Price DA, Cooke GS, Collini P, Cole J, Dunning J, Semple MG, Baillie JK; ISARIC4C Investigators; Rampling T, Houlihan CF. Callaby H, et al. Among authors: rampling t. Lancet Infect Dis. 2024 Nov 28:S1473-3099(24)00735-7. doi: 10.1016/S1473-3099(24)00735-7. Online ahead of print. Lancet Infect Dis. 2024. PMID: 39617024 No abstract available.
Investigation of a Human Case of Francisella tularensis Infection, United Kingdom, 2023.
Thompson A, Brooks T, Houlihan C, Rampling T, Umpleby H, Hansford K, Medlock J, Vaux A, Logan J, Frost A, Neale S, Wyllie S, Dodgson K, Haigh D, Halim I, Huq R, Riste M, Gordon NC. Thompson A, et al. Among authors: rampling t. Emerg Infect Dis. 2024 Oct;30(10):2188-2190. doi: 10.3201/eid3010.240479. Emerg Infect Dis. 2024. PMID: 39320338 Free PMC article.
A Cross-Sectional Evaluation of the Virtual Outpatient Management of People With Mpox.
Warrell CE, Chaudhry Z, Shawe-Taylor M, Mastoraki E, Delmonte Sen A, Rafferty H, De Wilton A, Mescall N, Houlihan C, Gothard P, Jungmann E, Logan S, Rampling T, Waters L, Browne R, Marks M, Shaw E. Warrell CE, et al. Among authors: rampling t. Open Forum Infect Dis. 2024 Jul 26;11(8):ofae413. doi: 10.1093/ofid/ofae413. eCollection 2024 Aug. Open Forum Infect Dis. 2024. PMID: 39113827 Free PMC article.
Anti-inflammatory therapy with nebulized dornase alfa for severe COVID-19 pneumonia: a randomized unblinded trial.
Porter JC, Inshaw J, Solis VJ, Denneny E, Evans R, Temkin MI, De Vasconcelos N, Aramburu IV, Hoving D, Basire D, Crissell T, Guinto J, Webb A, Esmail H, Johnston V, Last A, Rampling T, Lippert L, Helbig ET, Kurth F, Williams B, Flynn A, Lukey PT, Birault V, Papayannopoulos V. Porter JC, et al. Among authors: rampling t. Elife. 2024 Jul 16;12:RP87030. doi: 10.7554/eLife.87030. Elife. 2024. PMID: 39009040 Free PMC article. Clinical Trial.
Histopathological findings from the investigation of paediatric acute hepatitis of unknown aetiology, United Kingdom 2022.
Callaby H, McGuire E, Rajwal S, Stahlschmidt J, Hartley J, Brown RM, Deheragoda M, Quaglia A, Rampling T, Houlihan CF, Claire Gordon N, Brown CS, Simmons R, Samson A, Mandal S, Grammatikopoulos T, Demirjian A. Callaby H, et al. Among authors: rampling t. J Pediatr Gastroenterol Nutr. 2024 Mar;78(3):534-538. doi: 10.1002/jpn3.12133. Epub 2024 Feb 8. J Pediatr Gastroenterol Nutr. 2024. PMID: 38327256
Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
RECOVERY Collaborative Group; Horby PW, Peto L, Staplin N, Campbell M, Pessoa-Amorim G, Mafham M, Emberson JR, Stewart R, Prudon B, Uriel A, Green CA, Dhasmana DJ, Malein F, Majumdar J, Collini P, Shurmer J, Yates B, Baillie JK, Buch MH, Day J, Faust SN, Jaki T, Jeffery K, Juszczak E, Knight M, Lim WS, Montgomery A, Mumford A, Rowan K, Thwaites G, Haynes R, Landray MJ. RECOVERY Collaborative Group, et al. Nat Commun. 2024 Jan 31;15(1):924. doi: 10.1038/s41467-023-43644-x. Nat Commun. 2024. PMID: 38296965 Free PMC article. Clinical Trial.
Immunogenicity and safety of AZD2816, a beta (B.1.351) variant COVID-19 vaccine, and AZD1222 (ChAdOx1 nCoV-19) as third-dose boosters for previously vaccinated adults: a multicentre, randomised, partly double-blinded, phase 2/3 non-inferiority immunobridging study in the UK and Poland.
Ramasamy MN, Kelly EJ, Seegobin S, Dargan PI, Payne R, Libri V, Adam M, Aley PK, Martinez-Alier N, Church A, Jepson B, Khan M, Matthews S, Townsend GT, Vekemans J, Bibi S, Swanson PA 2nd, Lambe T, Pangalos MN, Villafana T, Pollard AJ, Green JA; AZD2816 Study Group. Ramasamy MN, et al. Lancet Microbe. 2023 Nov;4(11):e863-e874. doi: 10.1016/S2666-5247(23)00177-5. Epub 2023 Sep 29. Lancet Microbe. 2023. PMID: 37783221 Free article. Clinical Trial.
79 results